4.8 Article

In vivo directed differentiation of pluripotent stem cells for skeletal regeneration

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1218052109

Keywords

-

Funding

  1. National Institutes of Health (NIH) [1F32AR057302-02, 5U01HL099776, DP2OD004437, AG036142, AI085575, 1 R21 DE019274-01, RC2 DE020771-0, RC1 HL100490, 5RC2DE20771-2, R01-HL058770]
  2. Oak Foundation
  3. California Institute for Regenerative Medicine [RL1-00662]
  4. Hagey Laboratory for Pediatric Regenerative Medicine
  5. Stinehart/Reed awards

Ask authors/readers for more resources

Pluripotent cells represent a powerful tool for tissue regeneration, but their clinical utility is limited by their propensity to form teratomas. Little is known about their interaction with the surrounding niche following implantation and how this may be applied to promote survival and functional engraftment. In this study, we evaluated the ability of an osteogenic microniche consisting of a hydroxyapatite-coated, bone morphogenetic protein-2-releasing poly-L-lactic acid scaffold placed within the context of a macroenvironmental skeletal defect to guide in vivo differentiation of both embryonic and induced pluripotent stem cells. In this setting, we found de novo bone formation and participation by implanted cells in skeletal regeneration without the formation of a teratoma. This finding suggests that local cues from both the implanted scaffold/cell micro-and surrounding macroniche may act in concert to promote cellular survival and the in vivo acquisition of a terminal cell fate, thereby allowing for functional engraftment of pluripotent cells into regenerating tissue.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available